EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,943 | +19.5% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $14,175 | -54.5% | 2,250 | -40.0% | 0.00% | 0.0% |
| Q1 2022 | $31,125 | +166.5% | 3,750 | +66.7% | 0.00% | – |
| Q4 2021 | $11,678 | -22.3% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $15,030 | -21.6% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,170 | -3.7% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,913 | -28.0% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $27,653 | +51.0% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $18,315 | +163.1% | 2,250 | +210.3% | 0.00% | – |
| Q2 2020 | $6,960 | +70.6% | 725 | +20.8% | 0.00% | – |
| Q1 2020 | $4,080 | -54.4% | 600 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $8,940 | +45.4% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,150 | +190.1% | 600 | +200.0% | 0.00% | – |
| Q2 2019 | $2,120 | -24.2% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $2,796 | +37.6% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $2,032 | -15.3% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $2,400 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |